TY - JOUR
T1 - Chrebp Deletion and Mild Protein Restriction Additively Decrease Muscle and Bone Mass and Function
AU - Deguchi, Kanako
AU - Ushiroda, Chihiro
AU - Hidaka, Shihomi
AU - Tsuchida, Hiromi
AU - Yamamoto-Wada, Risako
AU - Seino, Yusuke
AU - Suzuki, Atsushi
AU - Yabe, Daisuke
AU - Iizuka, Katsumi
N1 - Publisher Copyright:
© 2025 by the authors.
PY - 2025/2
Y1 - 2025/2
N2 - Background/Objectives: Carbohydrate and protein restriction are associated with sarcopenia and osteopenia, but the underlying mechanisms remain unclear. We aimed to determine whether mild protein restriction affects muscle and bone function in wild-type (WT) and homozygous carbohydrate response element binding protein (Chrebp) knockout (KO) mice. Methods: Eighteen-week-old male wild-type and homozygous carbohydrate response element binding protein (Chrebp) knockout (KO) mice were fed a control diet (20% protein) or a low-protein diet (15% protein) for 12 weeks. We estimated the muscle weight and limb grip strength as well as the bone mineral density, bone structure, and bone morphometry. Results: Chrebp deletion and a low-protein diet additively decreased body weight (WT control–KO low-protein: mean difference with 95% CI, 8.7 [6.3, 11.0], p < 0.0001) and epidydimal fat weight (1.0 [0.7, 1.2], p < 0.0001). Chrebp deletion and a low-protein diet additively decreased tibialis anterior muscle weight (0.03 [0.01, 0.05], p = 0.002) and limb grip strength (63.9 [37.4, 90.5], p < 0.0001) due to a decrease in insulin/insulin-like growth factor 1 mRNA and an increase in myostatin mRNA. In contrast, Chrebp deletion increased bone mineral density (BMD) (WT control–KO control: –6.1 [–1.0, –2.3], p = 0.0009), stiffness (–21.4 [–38.8, –4.1], p = 0.011), cancellous bone BV/TV (–6.517 [–10.99, –2.040], p = 0.003), and the number of trabeculae (–1.1 [–1.8, –0.5], p = 0.0008). However, in KO mice, protein restriction additively decreased BMD (KO control–KO low-protein: 8.1 [4.3, 11.9], p < 0.0001), bone stiffness (38.0 [21.3, 54.7], p < 0.0001), cancellous bone BV/TV (7.7 [3.3, 12.2], p = 0.006), and the number of trabeculae (1.2 [0.6, 1.9], p = 0.0004). The effects of mild protein restriction on bone formation parameters (osteoid volume (WT control–WT low-protein: –1.7 [–2.7, –0.7], p = 0.001) and the osteoid surface (–11.2 [–20.8, –1.5], p = 0.02) were observed only in wild-type (WT) mice. The levels of bone resorption markers, such as the number of osteoclasts on the surface, the number of osteoclasts, and surface erosion, did not differ between the groups. Conclusions: Both Chrebp deletion and protein restriction led to a decrease in muscle and bone function; therefore, an adequate intake of carbohydrates and proteins is important for maintaining muscle and bone mass and function. Further studies will be needed to elucidate the mechanisms by which ChREBP deletion and a low-protein diet cause osteosarcopenia.
AB - Background/Objectives: Carbohydrate and protein restriction are associated with sarcopenia and osteopenia, but the underlying mechanisms remain unclear. We aimed to determine whether mild protein restriction affects muscle and bone function in wild-type (WT) and homozygous carbohydrate response element binding protein (Chrebp) knockout (KO) mice. Methods: Eighteen-week-old male wild-type and homozygous carbohydrate response element binding protein (Chrebp) knockout (KO) mice were fed a control diet (20% protein) or a low-protein diet (15% protein) for 12 weeks. We estimated the muscle weight and limb grip strength as well as the bone mineral density, bone structure, and bone morphometry. Results: Chrebp deletion and a low-protein diet additively decreased body weight (WT control–KO low-protein: mean difference with 95% CI, 8.7 [6.3, 11.0], p < 0.0001) and epidydimal fat weight (1.0 [0.7, 1.2], p < 0.0001). Chrebp deletion and a low-protein diet additively decreased tibialis anterior muscle weight (0.03 [0.01, 0.05], p = 0.002) and limb grip strength (63.9 [37.4, 90.5], p < 0.0001) due to a decrease in insulin/insulin-like growth factor 1 mRNA and an increase in myostatin mRNA. In contrast, Chrebp deletion increased bone mineral density (BMD) (WT control–KO control: –6.1 [–1.0, –2.3], p = 0.0009), stiffness (–21.4 [–38.8, –4.1], p = 0.011), cancellous bone BV/TV (–6.517 [–10.99, –2.040], p = 0.003), and the number of trabeculae (–1.1 [–1.8, –0.5], p = 0.0008). However, in KO mice, protein restriction additively decreased BMD (KO control–KO low-protein: 8.1 [4.3, 11.9], p < 0.0001), bone stiffness (38.0 [21.3, 54.7], p < 0.0001), cancellous bone BV/TV (7.7 [3.3, 12.2], p = 0.006), and the number of trabeculae (1.2 [0.6, 1.9], p = 0.0004). The effects of mild protein restriction on bone formation parameters (osteoid volume (WT control–WT low-protein: –1.7 [–2.7, –0.7], p = 0.001) and the osteoid surface (–11.2 [–20.8, –1.5], p = 0.02) were observed only in wild-type (WT) mice. The levels of bone resorption markers, such as the number of osteoclasts on the surface, the number of osteoclasts, and surface erosion, did not differ between the groups. Conclusions: Both Chrebp deletion and protein restriction led to a decrease in muscle and bone function; therefore, an adequate intake of carbohydrates and proteins is important for maintaining muscle and bone mass and function. Further studies will be needed to elucidate the mechanisms by which ChREBP deletion and a low-protein diet cause osteosarcopenia.
KW - bone mineral density
KW - carbohydrate
KW - carbohydrate binding protein
KW - fat
KW - muscle mass
KW - protein
UR - https://www.scopus.com/pages/publications/85217684163
UR - https://www.scopus.com/pages/publications/85217684163#tab=citedBy
U2 - 10.3390/nu17030488
DO - 10.3390/nu17030488
M3 - Article
C2 - 39940346
AN - SCOPUS:85217684163
SN - 2072-6643
VL - 17
JO - Nutrients
JF - Nutrients
IS - 3
M1 - 488
ER -